LRRD1
Leucine-rich repeat and death domain-containing protein 1
Also known as: IMAGE:4798971, LRRD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A4D1F6
- Gene
- LRRD1
- Ensembl
- ENSG00000240720
- Chromosome
- 7
- Canonical length
- 860 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to be involved in signal transduction. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
860 residues, UniProt reviewed canonical sequence.
>A4D1F6|LRRD1
1 MSEKEGMSEV LEDTISQFRK ESRSQSMKEP GFIKETSNLI NEASDYLEGK SSNQIYETHP
61 RQNTLESTSS SGRKSKRNEE QKKNLQFSET STRTGTSQSL SSLTGRTAEY QALVNFLSHE
121 TVGEVSPQVS EENQKQLGLG ADNFTVNLEA KGLQEFPKDI LKIKYVKYLY LDKNQIKTFQ
181 GADSGDLLGL EILSLQENGL SSLPSEIQLL HNLRILNVSH NHISHIPKEI SQLGNIRQLF
241 FYNNYIENFP SDLECLGNLE ILSLGKNKLR HIPDTLPSLK TLRVLNLEYN QLTTFPKALC
301 FLPKLISLDL TGNLISSLPK EIRELKNLET LLMDHNKLTF LAVEIFQLLK IKELQLADNK
361 LEVISHKIEN FRELRILILD KNLLKNIPEK ISCCAMLECL SLSDNKLTEL PKYIHKLNNL
421 RKLHVNRNNM VKITDCISHL NNICSLEFSG NIITDVPIEI KNCQKIIKIE LSYNKIMYFP
481 LGLCALDSLY YLSVNGNYIS EIPVDISFSK QLLHLELSEN KLLIFSEHFC SLINLKYLDL
541 GKNQIKKIPA SISNMISLHV LILCCNKFET FPRELCTLEN LQVLDLSENQ LQKISSDICN
601 LKGIQKLNFS SNQFIHFPIE LCQLQSLEQL NISQIKGRKL TRLPGELSNM TQLKELDISN
661 NAIREIPRNI GELRNLVSLH AYNNQISYLP PSLLSLNDLQ QLNLSGNNLT ALPSAIYNIF
721 SLKEINFDDN PLLRPPVEIC KGKQLYTIAR YLQRADERDE KILEKIFKIV ANNITETNFE
781 FLCQKLNLAN SETDMPTKST VSLSERAHQA LVIWKTQSNK LSLTAAALRD QLIRALTMIG
841 AYEIMDKITA LNLFTRAIKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- testis: 14 nTPM
- retina: 0.4 nTPM
- bone marrow: 0.3 nTPM
- epididymis: 0.3 nTPM
- skin: 0.3 nTPM
- cerebellum: 0.2 nTPM
Single-cell type
- late spermatids: 12 nCPM
- early spermatids: 4 nCPM
- renal collecting duct intercalated cells: 2.2 nCPM
- distal convoluted tubule cells: 1.6 nCPM
- loop of henle epithelial cells: 1.6 nCPM
- proximal tubule cells: 1.6 nCPM
Immune cell
- basophil: 0.7 nTPM
- neutrophil: 0.5 nTPM
- classical monocyte: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- memory CD4 T-cell: 0.1 nTPM
Brain region
- cerebellum: 6.3 nTPM
- white matter: 5.3 nTPM
- hypothalamus: 4.8 nTPM
- cerebral cortex: 4.7 nTPM
- pons: 4.6 nTPM
- medulla oblongata: 4.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.53
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Death domain
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Death-like domain superfamily
- Leucine-rich repeat domain superfamily
- Leucine-rich repeat domain-containing protein
- Disease resistance R13L4/SHOC-2-like, LRR domain
- Leucine Rich Repeat
- Leucine rich repeat
- Leucine-rich repeat region
- LRRD1, death domain
- Lrrd1 death domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRD1 as an antibody target. Whether an autoantibody or antibody against LRRD1 could matter depends on whether native LRRD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRRD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...